Glooko Stock

Unified platform for Diabetes management

Sign up today and learn more about Glooko Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.



Notable Investors

Canaan Partners


Mountain View CA, US

Total Funding


About Glooko Stock

Glooko is the universal diabetes platform that provides insights to improve outcomes for people with diabetes (PWDs) and their care teams. Glooko connects to the world’s most popular diabetes devices, major fitness and activity trackers and supplies personalized, timely patient information such as glucose level, food, insulin, medications, blood pressure, diet and weight data. Trusted by the world’s leaders in diabetes care, we are in over 7,000 clinical locations and used by over 1.5 million PWDs in 23 countries across 15 languages. Learn more by visiting


Funding History

November 2010$1.0M
January 2012$3.5M
January 2014$7.0M
March 2015$16.5M
September 2016$8.0M
June 2017$35.0M


Chief Executive Officer

Russ Johannesson


Yogen Dalal

Chief Medical Officer

Michael S. Greenfield

Chief Commercial Officer

David Conn


prnewswire - May, 9 2023

Glooko Unveils Redesigned Mobile App

mobihealthnews - Mar, 5 2019

Eversense CGM to integrate with Glooko

mobihealthnews - Jun, 12 2018

Glooko launches diabetes analytics platform

mobihealthnews - Mar, 16 2018

Sharp Rees-Stealy Medical Group

cbinsights - Oct, 26 2016

Walmart To Buy Jet For $3B

alexdanco - Feb, 2 2016

Full Stack Rehab

vator - Jan, 24 2016

How does Glooko make money?

massdevice - Jan, 12 2016

The 5 biggest medtech stories of 2015

EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As: